[go: up one dir, main page]

NO20052553L - Cobalaminanalyse. - Google Patents

Cobalaminanalyse.

Info

Publication number
NO20052553L
NO20052553L NO20052553A NO20052553A NO20052553L NO 20052553 L NO20052553 L NO 20052553L NO 20052553 A NO20052553 A NO 20052553A NO 20052553 A NO20052553 A NO 20052553A NO 20052553 L NO20052553 L NO 20052553L
Authority
NO
Norway
Prior art keywords
holotc
sample
specific binding
binding partner
cobalaminanalyse
Prior art date
Application number
NO20052553A
Other languages
English (en)
Other versions
NO338279B1 (no
NO20052553D0 (no
Inventor
Lars Orning
Anne Rian
Original Assignee
Axis Shield Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227544A external-priority patent/GB0227544D0/en
Priority claimed from GB0228674A external-priority patent/GB0228674D0/en
Priority claimed from GB0307727A external-priority patent/GB0307727D0/en
Application filed by Axis Shield Asa filed Critical Axis Shield Asa
Publication of NO20052553D0 publication Critical patent/NO20052553D0/no
Publication of NO20052553L publication Critical patent/NO20052553L/no
Publication of NO338279B1 publication Critical patent/NO338279B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SAMMENDRAG Foreliggende oppfinnelse tilveiebringer en spesifikk bindingspartner for holoTC som har en spesifisitet for holoTC fremfor apoTC på minst 40 ganger og en analysemetode for analyse med hensyn til holoTC i en prøve, hvori metoden omfatter å kontakte prøven med en spesifikk bindingspartner for holoTC og detektere de resulterende konjugatene.
NO20052553A 2002-11-26 2005-05-26 Fremgangsmåte for å identifisere spesifikke bindingspartnere, spesifikk bindingspartner og analysemetode for analyse for holoTC i en prøve, samt sett NO338279B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0227544A GB0227544D0 (en) 2002-11-26 2002-11-26 Assay
GB0228674A GB0228674D0 (en) 2002-12-09 2002-12-09 Assay
GB0307727A GB0307727D0 (en) 2003-04-03 2003-04-03 Assay
PCT/GB2003/005167 WO2004048414A2 (en) 2002-11-26 2003-11-26 Holo-transcobalamins binding partners and their use in cobalamin assay

Publications (3)

Publication Number Publication Date
NO20052553D0 NO20052553D0 (no) 2005-05-26
NO20052553L true NO20052553L (no) 2005-08-19
NO338279B1 NO338279B1 (no) 2016-08-08

Family

ID=32397649

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052553A NO338279B1 (no) 2002-11-26 2005-05-26 Fremgangsmåte for å identifisere spesifikke bindingspartnere, spesifikk bindingspartner og analysemetode for analyse for holoTC i en prøve, samt sett

Country Status (13)

Country Link
US (3) US7632648B2 (no)
EP (1) EP1565490B1 (no)
JP (1) JP4566911B2 (no)
AT (1) ATE466884T1 (no)
AU (1) AU2003286272B2 (no)
CA (1) CA2505995C (no)
DE (1) DE60332479D1 (no)
DK (1) DK1565490T3 (no)
ES (1) ES2345712T3 (no)
NO (1) NO338279B1 (no)
PT (1) PT1565490E (no)
SI (1) SI1565490T1 (no)
WO (1) WO2004048414A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234824A (en) * 1963-03-04 1966-02-15 Garland E Lyvers Tool for removing internal selflocking retaining rings
ES2345712T3 (es) * 2002-11-26 2010-09-30 Axis-Shield Asa Parejas de union especifica de holo-transcobalaminas y su uso en el ensayo de la cobalamina.
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US8524454B2 (en) 2006-04-07 2013-09-03 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
EP2265632B1 (en) * 2008-03-27 2015-01-07 Elevation Biotech (PTY) LTD. Cd4-related polypeptides and methods of use
WO2010151329A1 (en) * 2009-06-24 2010-12-29 Seventh Sense Biosystems, Inc. Assays involving colorimetric signaling
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
CA2871116A1 (en) * 2012-05-14 2013-11-21 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6325216B1 (en) * 1993-04-30 2001-12-04 Tuboscope I/P, Inc. Screen apparatus for vibratory separator
GB0004042D0 (en) * 2000-02-21 2000-04-12 Axis Shield Asa Assay
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
ES2345712T3 (es) * 2002-11-26 2010-09-30 Axis-Shield Asa Parejas de union especifica de holo-transcobalaminas y su uso en el ensayo de la cobalamina.

Also Published As

Publication number Publication date
US8647831B2 (en) 2014-02-11
ATE466884T1 (de) 2010-05-15
US20060240570A1 (en) 2006-10-26
DE60332479D1 (de) 2010-06-17
PT1565490E (pt) 2010-07-13
NO338279B1 (no) 2016-08-08
CA2505995C (en) 2012-04-17
EP1565490B1 (en) 2010-05-05
EP1565490A2 (en) 2005-08-24
JP2007516408A (ja) 2007-06-21
US20110020379A1 (en) 2011-01-27
AU2003286272A1 (en) 2004-06-18
US8802382B2 (en) 2014-08-12
US20140147868A1 (en) 2014-05-29
WO2004048414A3 (en) 2004-08-19
US7632648B2 (en) 2009-12-15
SI1565490T1 (sl) 2010-09-30
DK1565490T3 (da) 2010-08-23
WO2004048414A2 (en) 2004-06-10
ES2345712T3 (es) 2010-09-30
JP4566911B2 (ja) 2010-10-20
NO20052553D0 (no) 2005-05-26
CA2505995A1 (en) 2004-06-10
AU2003286272B2 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
DE60136034D1 (de) Molekular-Modifikations-Assays
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE247830T1 (de) Verbesserungen in oder in bezug auf spezifische bindungsassays
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
ATE497023T1 (de) Nanosensoren und entsprechende technologien
WO2001049823A3 (en) Assays for detection of bacillus anthracis
WO2007035633A3 (en) Screening assays and methods
MXPA01010640A (es) Medicion y uso de interacciones moleculares.
WO2005106036A3 (en) Methods and compositions for assaying analytes
BR0316384A (pt) Imunoensaio não competitivo para analitos pequenos
DE60013320D1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
WO2006026601A3 (en) Homogeneous enzyme immunoassay for oral fluid
WO2002088376A3 (en) Multiple simultaneous antigen detection by immunohistochemistry
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2002008461A3 (en) A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS
WO2008060483A3 (en) Protein-protein interaction biosensors and methods of use thereof
TW200739073A (en) Test sensor reagent having cellulose polymers
NO20052553D0 (no) Cobalaminanalyse.
AU3534001A (en) Method for identifying a mark applied on a solid body
WO2005000876A3 (en) Ring finger family proteins and uses related thereto
DE69732034D1 (de) Assay-verfahren
WO2005035720A3 (en) Methods and use of binding components for improving assay specificity
WO2005014847A3 (en) Reagents, methods and kits for detecting feed enzymes
WO2004027094A3 (en) Assay for camp based on exclusive binding of camp to the b-binding sites of camp dependent protein kinase (capk)
GB0409775D0 (en) Assay

Legal Events

Date Code Title Description
MK1K Patent expired